ClinicalTrials.gg
Enrolling by invitationNCT05993572HEAT-YASAMUpdated Dec 6, 2023

HEalthy Aging Team Supported Home-care Services (HEAT-YASAM)

An observational study in Frailty, Dementia and Depression, sponsored by Gulhane Training and Research Hospital. Enrolling by invitation at 1 site in Turkey. Open to participants aged 80 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-12-06.

Sponsored by Gulhane Training and Research Hospital · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Dec 2024, 1 year 11 months ago, but the record still lists the study as enrolling by invitation.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
2,000
Ages
80 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 83 studies in Frailty with a site in Turkey — 24 open to participants now, 27 under way, none of them phase 3. Frailty · Turkey.

Planned enrollment
2nd of 67
2,000 · median 138
Started
2023
with 13 others
Observational
67 of 83
21 open now
Primary completion
2024-12
later than 5 of 26 live
Registered
22nd of 83
by date

Among the 83 studies in Frailty with a site in Turkey, this one is the 2nd largest by planned enrollment of the 67 observational ones that give a count, is one of 14 that started in 2023, is one of 67 observational ones, reaches primary completion later than 5 of the 26 other live ones, and was the 22nd registered.

Frailty

1,291 studies on the registry are indexed under Frailty; 454 are open to participants now.

Browse Frailty studies →

Open to participants now

24 of the 83 studies in Frailty with a site in Turkey are open now. Recruiting first, the newest first:

18 more — sign in →

All 24 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 299 Frailty studies recruiting now, 235 (79%) set no upper age limit and 10 (3%) stop at 75 or younger; 7 take children under 18; 66 take healthy volunteers.

This study: 80 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 83 studies in Frailty with a site in Turkey, or all of them as a file.
02

Study summary

Depending on the YASAM project which was established to home-visit evaluate community-dwelling older adults (80 years of age and over), we aimed to determine the prevalence (prevalence) of geriatric syndromes (dependence, frailty, malnutrition, depression, dementia, comorbidity burden, polypharmacy) in these individuals and to determine possible changes in the follow-up of the patients during the 2-year follow-up period. (HEAVEN trial)

Read the detailed description

Individuals over the age of 80 who will participate in the YASAM project will first be informed by phone and their appointments will be made. Subsequently, a home visit will be conducted after obtaining verbal and written consent from the patients and their relatives.

The chronic diseases and medications of the patients will be questioned and controlled from the electronic data set. To determine the level of frailty and dependency, the Katz, Lawton-Brody, and Clinical Frailty scales will be filled in, respectively, by the previously trained health personnel, by interviewing their relatives. Mini-Cog, Mini Mental Status Assessment, Mini Nutrition Assessment, and Geriatric Depression (Yesavage) Assessments will be planned. According to dependency status, individuals will be re-evaluated in the 1st or 2nd month. If the patients are fully independent, control follow-up is planned in the 3rd month. Written file records will be created by obtaining the consent of the patients and their relatives at each patient visit. Each team will be responsible for the follow-up of 300 patients. It is planned to include a total of 6000 individuals in the first phase, which is carried out in 20 centers throughout the province of Balıkesir and whose coordination center is Atatürk city hospital. In the follow-ups, it is planned to include the whole cohort consisting of 40 thousand individuals over the age of 80, by increasing the number of teams. The short-term results of the patient's follow-up (1st, 3rd, and 6th-month results), changes in mortality, addiction, frailty level, and changes in nutrition and cognitive functions within the specified period will be evaluated as short-term results. It is aimed to record the long-term outcomes (1st and 2nd year) of the same variables.

Since the whole population will be included in the study, sample size and power analysis were not performed.

03

Conditions studied

  • Frailty
  • Dementia
  • Depression
  • Malnutrition
  • Old Age; Debility
  • Drug Use
04

Who can participate

Ages eligible
80 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

It is planned to include a total of 6000 individuals in the first phase, which is carried out in 20 centers throughout the province of Balıkesir (rural and central area) and whose coordination center is Balikesir Atatürk City Hospital. In the follow-ups, it is planned to include the whole cohort consisting of individuals over the age of 40 thousand 80, by increasing the number of teams.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 80 years and over older adults
  • individuals giving verbal and written consent for the YASAM project

Exclusion criteria

Exclusion Criteria:

  • \<80 years older adults
  • those who did not give verbal and written consent for the YASAM project
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
2,000 participants (estimated)
Target follow-up
2 Years
Patient registry
Yes

Interventions

  • Diagnostic testComprehensive Geriatric Assessment

    Comprehensive Geriatric Assessments include functional status, fraility comorbidity, cognition, mental health, social support, nutrition, and geriatric syndromes

06

What researchers measure

Primary outcomes

  1. Short term Healthy Aging status (mortality)

    Outcomes were evaluated according to the national electronic database.

    Time frame: 1-,3-,6- month

  2. Short term Healthy Aging status (changes dependency )

    Outcomes were evaluated according to the specific test Katz scales the 1 is minimum and 6 is maximum value for scale, and higher scores mean a better outcome, higher scores mean a better outcome for dependency)

    Time frame: 1-,3-,6- month

  3. Short term Healthy Aging status (changes in frailty level)

    Outcomes were evaluated according to the specific test (Fraility via Clinical fraility scales the 1 is minimum and 9 is maximum value for scale, and higher scores mean a worse outcome).

    Time frame: 1-,3-,6- month

  4. Short term Healthy Aging status (changes in nutrition)

    Outcomes were evaluated according to the specific test (MNA scale for nutritional status the 0 is minimum and 14 is maximum value for scale, and higher scores mean a better outcome).

    Time frame: 1-,3-,6- month

  5. Short term Healthy Aging status (changes in cognitive functions)

    Outcomes were evaluated according to the specific test (cognitive functions with MMSE scale, the 0 is minimum and 30 is maximum value for scale, and higher scores mean a better outcome)

    Time frame: 1-,3-,6- month

  6. Short term Healthy Aging status (changes in mood)

    Outcomes were evaluated according to the specific test (Outcomes were evaluated according to the specific test ( Yesavage for Depression status the 0 is minimum and 15 is maximum value for scale, and higher scores mean a worse outcome)

    Time frame: 1-,3-,6- month

  7. Short term Healthy Aging status (changes in mobility status)

    Outcomes were evaluated according to the specific test (Chair stand test higher scores (\>13,5 seconds) means a worse outcome for mobility status).

    Time frame: 1-,3-,6- month

  8. Long term Healthy Aging status (mortality)

    Outcomes were evaluated according to the national electronic database.

    Time frame: 1- and 2- year

  9. Long term Healthy Aging status (changes dependency )

    Outcomes were evaluated according to the specific test Katz scales the 1 is minimum and 6 is maximum value for scale, and higher scores mean a better outcome, higher scores mean a better outcome for dependency)

    Time frame: 1- and 2- year

  10. Long term Healthy Aging status (changes in frailty level)

    Outcomes were evaluated according to the specific test (Fraility via Clinical fraility scales the 1 is minimum and 9 is maximum value for scale, and higher scores mean a worse outcome.)

    Time frame: 1- and 2- year

  11. Long term Healthy Aging status (changes in nutrition)

    Outcomes were evaluated according to the specific test (MNA scale for nutritional status the 1 is minimum and 14 is maximum value for scale, and higher scores mean a better outcome).

    Time frame: 1- and 2- year

  12. Long term Healthy Aging status (changes in cognitive functions)

    Outcomes were evaluated according to the specific test (cognitive functions with MMSE scale, the 0 is minimum and 30 is maximum value for scale, and higher scores mean a better outcome).

    Time frame: 1- and 2- year

  13. Long term Healthy Aging status (changes in mood)

    Outcomes were evaluated according to the specific test ( Yesavage scale for Depression status the 0 is minimum and 15 is maximum value for scale, and higher scores mean a worse outcome).

    Time frame: 1- and 2- year

  14. Long term Healthy Aging status (changes in mobility status)

    Outcomes were evaluated according to the specific test (Outcomes were evaluated according to the specific test (Chair stand test higher scores (\>13,5 seconds) means a worse outcome for mobility status).

    Time frame: 1- and 2- year

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2023 (actual). Primary completion is estimated for Dec 2024, 17 months after the start.

Of 291 non-industry observational studies under Frailty, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 55. This study's planned 17 months is below that.

Counting every sponsor, half of 294 studies reached it within 29 months; a quarter within 12 and three quarters within 55.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 21, 2023
First posted
Aug 15, 2023
StartActual
Jun 15, 2023
Primary completionEst.
Dec 1, 2024
CompletionEst.
Dec 1, 2025
Last update
Dec 6, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 6, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05993572
Lead sponsor
Gulhane Training and Research Hospital
Collaborators
Provincial Health Services Authority
Responsible party
Bilal Katipoglu (Associate Professor, Gulhane Training and Research Hospital) — Principal investigator
First posted
Aug 15, 2023
Start date
Jun 15, 2023
Primary completion
Dec 1, 2024 (estimated)
Completion
Dec 1, 2025 (estimated)
Last update
Dec 6, 2023

Study contacts

Bilal Katipoglu
study director · Gulhane Training and Research Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion